Ductal carcinoma in situ (DCIS) of the breast: perspectives on biology and controversies in current management.
about
Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a case report.Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plansTamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsMeta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ.
P2860
Ductal carcinoma in situ (DCIS) of the breast: perspectives on biology and controversies in current management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ductal carcinoma in situ (DCIS ...... versies in current management.
@en
type
label
Ductal carcinoma in situ (DCIS ...... versies in current management.
@en
prefLabel
Ductal carcinoma in situ (DCIS ...... versies in current management.
@en
P2093
P2860
P356
P1476
Ductal carcinoma in situ (DCIS ...... versies in current management.
@en
P2093
Christy A Russell
Isaac Schmale
Jessica Rayhanabad
Stephen F Sener
Stephen Liu
P2860
P304
P356
10.1002/JSO.22020
P577
2011-07-12T00:00:00Z